Mindfulness Walking Intervention to Enhance Resilience (iWalk)
University of Illinois at Urbana-Champaign · NCT07285954
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 18–110 · All sexes
- Healthy volunteers
- Accepted
- Study type
- Interventional · Not applicable
- Target enrollment
- 90
- US sites recruiting
- 1
- Study start
- June 1, 2025
- Record last updated
- December 16, 2025
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
This study is a randomized controlled trial of the walking meditation intervention (iWalk) program, a multi-component intervention integrating walking meditation, education, and group sessions designed to enhance resilience in individuals with multiple sclerosis (MS).
The objectives are to evaluate
- Recruitment capability and retention rates,
- Acceptability and adherence to the intervention,
- Feasibility of assessment procedures, and
- Preliminary effects on psychological, physiological, and behavioral outcomes.
Being studied: iWalk Program
Conditions: Neurodegenerative Disease; EEG; Mindfulness; Adults
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- 18 years or older,
- clinical diagnosis of a neurodegenerative disease such as multiple sclerosis, Alzheimer's disease, Parkinson's disease, stroke, etc.,
- have not practiced meditation regularly (e.g., 10 mins per day) and have never attended any meditation classes or community programs,
- never received meditation training via coaching/certification/life coaching,
- have internet access,
- with no severe cognitive impairment, i.e., have a score of ≥ 21 on Modified Telephonic Interview for Cognitive Status (TICS-M),
- be able to walk with or without an assistive device (Patient determined Disease Steps score ranged from 0-6),
- are willing to be randomized to an intervention or a control group,
- are willing to wear Fitbit (a wrist smart watch) for eight weeks,
- are individuals who are right-handed according to the Edinburgh Handedness Questionnaire,
- are willing to participate in all assessments, including in-person testing using electroencephalography (EEG) and cognitive tests, online survey/questionnaires, and online interviews or focus group discussions,
- are willing to wear a Hexoskin t-shirt, which is a heart rate variability monitor, while doing the assessments in person.
Exclusion Criteria
Participants who cannot speak, read, write, or listen in English.
Recruiting US locations
University of Illinois Urbana-Champaign
Urbana, IL 61801
Site contact: Chung-Yi Chiu · 217-244-6435 · chiucy@illinois.edu
Study contacts (from the official record)
- Chung-Yi Chiu · 12172446435 · chiucy@illinois.edu
- Vaishnavi Sridharan · vs35@illinois.edu
Similar studies in Illinois
All healthy volunteers studies in Illinois →- RecruitingHealthy volunteers
J-RISE: Relevant Implementation Strategies to Eliminate the Social and Structural Barriers to HIV Services Among Justice-involved Black Men Who Have Sex With Men and Other Key Populations
University of Chicago
- Location
- Chicago, IL
- Eligibility basics
- Ages 18+
- RecruitingHealthy volunteersPhase 1/Phase 2
Phase 1/2 Study of Respiratory Syncytial Virus and Human Metapneumovirus (RSV+HMPV) Vaccine Candidate in Adults 60 Years of Age and Older
Sanofi
- Location
- Melrose Park, IL + 49 other US sites
- Eligibility basics
- Ages 60+
- RecruitingHealthy volunteersPhase 1
A Study to Assess Safety, Tolerability, and How Single and Multiple Injections or Infusions of ABBV-313 Affects the Body of Adult Participants
AbbVie
- Location
- Grayslake, IL + 1 other US site
- Eligibility basics
- Ages 18–55
- RecruitingHealthy volunteersPhase 1
A Study to Evaluate the Safety and Pharmacokinetics of Multiple Doses Upadacitinib, Tofacitinib, and Baricitinib in Healthy Adult Volunteers
AbbVie
- Location
- Grayslake, IL
- Eligibility basics
- Ages 18–65